Share this @internewscast.com
In order to establish this theory, researchers used mouse models to study the impact of chronic stress and depression.
Kireccbasi added: “The major finding is that repeated stress and the physiological and behavioural effects of hostile interactions appear to prevent the full beneficial changes to plaques that should be induced by lipid-lowering medications.”
What this means is the AHA’s study suggests poor mental health could counteract the effect of cholesterol lowering medications such as statins.
However, as the research has only been performed on mouse modes, more research is required in humans in order to establish this relationship.